2030, Marketing and Packaging - Drug Discovery Digest

Zebrafish Value Proposition for Cosmetic Testing

biobide

NOVEMBER 20, 2023

Background on the Cosmetics industry In 2022, the value of the global cosmetics market was estimated to be worth USD 262.21 projected by the year 2030. billion, with an annual growth of 4.2%

Packaging

Packaging Regulations Production Marketing

Regulatory Developments in Ophthalmology: Applying New FDA Guidance, Part One

The Premier Consulting Blog

MAY 4, 2023

The global ophthalmic drugs market size was valued at $33.81 billion in 2022 and is expected to grow approximately eight percent from 2023 to 2030 [1]. Market Analysis [2] Aloba O, et al. Now, these companies are required to comply with new guidance from the U.S. Update on FDA regulation of ophthalmic combination products.

FDA

FDA Packaging Compliance Regulations

Six Factors for Biotech Companies to Consider When Choosing Next-Generation Contract GMP/CMC Laboratories

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care.

Laboratories

Laboratories Assay Development Small Molecule Drug Development

GSK Consumer Healthcare commits to make over a billion toothpaste tubes recyclable by 2025 as part of its ongoing sustainability journey

The Pharma Data

MAY 18, 2021

GSK Consumer Healthcare (GSKCH), the world-leading consumer healthcare business, announced today that it is partnering with two global packaging suppliers to launch fully recyclable toothpaste tubes across its specialist and science-based oral health brands, including Sensodyne, parodontax and Aquafresh. Best’ in Germany.

Packaging

Packaging Science Marketing Production

GSK Consumer Healthcare leads oral care industry with launch of.

The Pharma Data

SEPTEMBER 6, 2021

The company is piloting this with its Dr.BEST GreenClean toothbrush, which builds new sustainable handle technology onto its previous innovations with sustainable bristles and packaging. The product’s 100% plastic free packaging includes GSKCH’s innovative cellulose window (which is also made with renewable cellulose.

Packaging

Packaging Production Science Marketing

SVG Ventures | THRIVE and Bayer Announce their Sustainability Challenge.

The Pharma Data

SEPTEMBER 10, 2021

The Sustainable Startup Award was presented to Haystack , a US based company that enables carbon market scalability by helping farmers and carbon markets quantify carbon accurately and cost-effectively. Today, SVG Ventures | THRIVE and Bayer announced the winners of their 2021 Sustainability Challenge.

Packaging

Packaging Science Marketing Production

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement

Vial

FEBRUARY 23, 2024

In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 billion and is expected to climb at a compound annual growth rate (CAGR) of 19.44% between 2023 and 2030.

Clinical Trials

Clinical Trials Clinical Research Trials Hospitals

Beyond Steel Tanks

Codon

MARCH 24, 2024

Novo Nordisk’s market capitalization ($442B) is already larger than the GDP of Denmark ( $404B ), the country where the company is headquartered. The market for semaglutide-based products is projected to swell to $71B in less than a decade. market with Wegovy will, by 2030, require about one million liters of production capacity.

Engineering

Engineering Vaccine Production RNA

Article Periodic Thank You Why comprehensive state-level bans on PFAS in products are faltering

Agency IQ

JUNE 28, 2024

In 2030, the law will ban the use of any product with intentionally added PFAS, unless the Maine legislature determines that the product currently serves an unavoidable use. In addition, the law prohibits the sale of carpets or fabric treatments containing PFAS as of January 1, 2023.

Production

Production Regulations Compliance Packaging

Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results

The Pharma Data

JANUARY 9, 2021

We are proud to be a leader in the growing public health threat market, enabled by our development and manufacturing expertise, successful public-private partnerships, and broad portfolio of products and CDMO services. In working together, we envision protecting or enhancing 1 billion lives by 2030. Other 2021 Assumptions.

Government

Government Vaccine Production Licensing

Regeneron Reports Third Quarter 2020 Financial and Operating Results

The Pharma Data

NOVEMBER 5, 2020

Key Pipeline Progress Regeneron has more than 20 product candidates in clinical development, including five marketed products for which it is investigating additional indications. Assets: Cash and marketable securities. $. Non-GAAP net income per share – diluted (1). $. Business Highlights. REGENERON PHARMACEUTICALS, INC.

Production

Production FDA Trials FDA Approval

Analysis Chemical Thank You What we expect the EPA to do in December 2023

Agency IQ

DECEMBER 1, 2023

2060-AV59 Market-Based Approaches Under the National Pollutant Discharge Elimination System (NPDES) Program (Proposed Rule Stage) EPA supports market-based mechanisms to accomplish its mission to protect human health and the environment especially regarding nutrient management. Regan, Case No: 1:16-cv-00364-CRC (D.D.C.

Regulations

Regulations Production Compliance Science

Analysis Chemical Thank You The 174 regulations the EPA is currently working on

Agency IQ

DECEMBER 15, 2023

For this routine MUR, EPA will only consider new methods or method revisions for which a complete, acceptable method package has been received by January 7, 2022. Monitoring preparations are anticipated in 2027, with sample collection between 2028-2030 and reporting concluding in 2031.

Regulations

Regulations Compliance Production Government

Analysis Chemical Thank You Highlights of the EPA’s Unified Agenda for Spring 2023

Agency IQ

JUNE 16, 2023

For increased flexibility in bringing PIPs to market, a developer can also submit both. Market-based mechanisms include water quality trading under the Clean Water Act (CWA), an approach that may cost less than more traditional regulatory approaches. EPA is reviewing the comments received and is planning to issue a final rule.

Regulations

Regulations Compliance Production Science

Drug Discovery Digest

Zebrafish Value Proposition for Cosmetic Testing

Regulatory Developments in Ophthalmology: Applying New FDA Guidance, Part One

Trending Sources

Six Factors for Biotech Companies to Consider When Choosing Next-Generation Contract GMP/CMC Laboratories

GSK Consumer Healthcare commits to make over a billion toothpaste tubes recyclable by 2025 as part of its ongoing sustainability journey

GSK Consumer Healthcare leads oral care industry with launch of.

SVG Ventures | THRIVE and Bayer Announce their Sustainability Challenge.

The Evolution of Digital Patient Portals: Enhancing Healthcare Access and Engagement

Beyond Steel Tanks

Article Periodic Thank You Why comprehensive state-level bans on PFAS in products are faltering

Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results

Regeneron Reports Third Quarter 2020 Financial and Operating Results

Analysis Chemical Thank You What we expect the EPA to do in December 2023

Analysis Chemical Thank You The 174 regulations the EPA is currently working on

Analysis Chemical Thank You Highlights of the EPA’s Unified Agenda for Spring 2023

Stay Connected